Skip to main content

Table 2 Use of antidepressants, anxiolytics and sleeping medications among those with PHQ-9 ≥ 10 and GAD-7 ≥ 10

From: Prevalence of symptoms, ever having received a diagnosis and treatment of depression and anxiety, and associations with health service use amongst the general population in two Russian cities

  N with medication data Use of anti-depressants (N06A) Use of anxiolytics (N05B) Use of sleeping medication (N05C)
Moderate depression (PHQ-9 ≥ 10)
Total 334 1.5% 0.6% 1.5%
Men 86 0.0% 0.0% 0.0%
Women 248 2.0% 0.8% 2.0%
Moderate anxiety (GAD-7 ≥ 10)
Total 181 2.2% 0.6% 2.8%
Men 46 0.0% 0.0% 0.0%
Women 138 2.9% 0.7% 3.7%
Co-morbid moderate depression and anxiety (PHQ-9 & GAD-7 ≥ 10)
Total 121 3.3% 0.8% 3.3%
Men 26 0.0% 0.0% 0.0%
Women 95 4.2% 1.1% 4.2%